Candesic

Candesic is a leading specialist management consulting firm focused on healthcare, life sciences, pharmaceuticals, and medtech. It provides strategy development, commercial due diligence for investments and M&A/growth advisory to corporates, investors (including private equity), and public sector organizations such as the NHS. The company leverages deep medical and scientific expertise to deliver actionable insights for clients across Europe and globally[1][2][3][4].

It does not have its own clinical pipeline or products.

Founded in 2002 by Dr. Leonid Shapiro and other McKinsey alumni, Candesic has completed over 700 assignments worldwide[4]. The team includes around 40 professionals with backgrounds in medicine, science, business and technology[1][5]. Offices are located in London (HQ) and New York[2][5].

Key partners include Dr. Leonid Shapiro (Managing Partner), Marc Kitten (Senior Partner), Dr. Michelle Tempest (Senior Partner)[5].

Recognized multiple times as “Strategy Consultancy of the Year” by HealthInvestor among other awards[5].

No evidence of acquisition or being acquired.

No evidence of manufacturing capabilities or CDMO partnerships.

Not publicly traded.